Listed

Biomerica Inc

BMRANasdaqCIK 73290HealthcareFiscal year ends May 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.3m, Q1 FY2027
Operating income−$1.2m, Q1 FY2027
Net income−$1.2m, Q1 FY2027
Biomerica Inc, income statement, quarterly
Line itemUnitQ2 FY20242023-11-30Q3 FY20242024-02-29Q4 FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q4 FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q4 FY20262026-05-31Q1 FY20272026-08-31
Revenue$k1,567Revenue, Q2 FY2024, three months to 2023-11-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure1,017Revenue, Q3 FY2024, three months to 2024-02-29$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure1,116Revenue, Q4 FY2024, three months to 2024-05-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure1,807Revenue, Q1 FY2025, three months to 2024-08-31$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure1,636Revenue, Q2 FY2025, three months to 2024-11-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1,119Revenue, Q3 FY2025, three months to 2025-02-28$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure749Revenue, Q4 FY2025, three months to 2025-05-31$749.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure1,380Revenue, Q1 FY2026, three months to 2025-08-31$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure1,210Revenue, Q2 FY2026, three months to 2025-11-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure987Revenue, Q3 FY2026, three months to 2026-02-28$987.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure875Revenue, Q4 FY2026, three months to 2026-05-31$875.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure1,265Revenue, Q1 FY2027, three months to 2026-08-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Cost of revenue$k1,242Cost of revenue, Q2 FY2024, three months to 2023-11-30$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure1,166Cost of revenue, Q3 FY2024, three months to 2024-02-29$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure1,096Cost of revenue, Q4 FY2024, three months to 2024-05-31$1.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure1,518Cost of revenue, Q1 FY2025, three months to 2024-08-31$1.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure1,199Cost of revenue, Q2 FY2025, three months to 2024-11-30$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1,100Cost of revenue, Q3 FY2025, three months to 2025-02-28$1.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure993Cost of revenue, Q4 FY2025, three months to 2025-05-31$993.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure956Cost of revenue, Q1 FY2026, three months to 2025-08-31$956.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure1,159Cost of revenue, Q2 FY2026, three months to 2025-11-30$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1,031Cost of revenue, Q3 FY2026, three months to 2026-02-28$1.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure946Cost of revenue, Q4 FY2026, three months to 2026-05-31$946.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure1,162Cost of revenue, Q1 FY2027, three months to 2026-08-31$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Gross profit$k325Gross profit, Q2 FY2024, three months to 2023-11-30$325.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure(149)Gross profit, Q3 FY2024, three months to 2024-02-29−$149.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure20.0Gross profit, Q4 FY2024, three months to 2024-05-31$20.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure289Gross profit, Q1 FY2025, three months to 2024-08-31$289.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure437Gross profit, Q2 FY2025, three months to 2024-11-30$437.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure19.0Gross profit, Q3 FY2025, three months to 2025-02-28$19.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(244)Gross profit, Q4 FY2025, three months to 2025-05-31−$244.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure424Gross profit, Q1 FY2026, three months to 2025-08-31$424.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure51.0Gross profit, Q2 FY2026, three months to 2025-11-30$51.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(44.0)Gross profit, Q3 FY2026, three months to 2026-02-28−$44.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(71.0)Gross profit, Q4 FY2026, three months to 2026-05-31−$71.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure103Gross profit, Q1 FY2027, three months to 2026-08-31$103.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Research and development$k412Research and development, Q2 FY2024, three months to 2023-11-30$412.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure343Research and development, Q3 FY2024, three months to 2024-02-29$343.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure265Research and development, Q4 FY2024, three months to 2024-05-31$265.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure297Research and development, Q1 FY2025, three months to 2024-08-31$297.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure257Research and development, Q2 FY2025, three months to 2024-11-30$257.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure217Research and development, Q3 FY2025, three months to 2025-02-28$217.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure252Research and development, Q4 FY2025, three months to 2025-05-31$252.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure212Research and development, Q1 FY2026, three months to 2025-08-31$212.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure193Research and development, Q2 FY2026, three months to 2025-11-30$193.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure178Research and development, Q3 FY2026, three months to 2026-02-28$178.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure205Research and development, Q4 FY2026, three months to 2026-05-31$205.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure206Research and development, Q1 FY2027, three months to 2026-08-31$206.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Selling, general and administrative$k1,521Selling, general and administrative, Q2 FY2024, three months to 2023-11-30$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure1,508Selling, general and administrative, Q3 FY2024, three months to 2024-02-29$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure1,283Selling, general and administrative, Q4 FY2024, three months to 2024-05-31$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure1,360Selling, general and administrative, Q1 FY2025, three months to 2024-08-31$1.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure1,173Selling, general and administrative, Q2 FY2025, three months to 2024-11-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1,012Selling, general and administrative, Q3 FY2025, three months to 2025-02-28$1.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure1,068Selling, general and administrative, Q4 FY2025, three months to 2025-05-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure1,330Selling, general and administrative, Q1 FY2026, three months to 2025-08-31$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure1,231Selling, general and administrative, Q2 FY2026, three months to 2025-11-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1,076Selling, general and administrative, Q3 FY2026, three months to 2026-02-28$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure1,257Selling, general and administrative, Q4 FY2026, three months to 2026-05-31$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure1,124Selling, general and administrative, Q1 FY2027, three months to 2026-08-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Operating income$k(1,608)Operating income, Q2 FY2024, three months to 2023-11-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure(2,000)Operating income, Q3 FY2024, three months to 2024-02-29−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure(1,528)Operating income, Q4 FY2024, three months to 2024-05-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure(1,368)Operating income, Q1 FY2025, three months to 2024-08-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure(993)Operating income, Q2 FY2025, three months to 2024-11-30−$993.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(1,210)Operating income, Q3 FY2025, three months to 2025-02-28−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,564)Operating income, Q4 FY2025, three months to 2025-05-31−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure(1,118)Operating income, Q1 FY2026, three months to 2025-08-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure(1,373)Operating income, Q2 FY2026, three months to 2025-11-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(1,298)Operating income, Q3 FY2026, three months to 2026-02-28−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,533)Operating income, Q4 FY2026, three months to 2026-05-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure(1,227)Operating income, Q1 FY2027, three months to 2026-08-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k8.0Income tax, Q2 FY2024, three months to 2023-11-30$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure4.0Income tax, Q3 FY2024, three months to 2024-02-29$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure7.0Income tax, Q4 FY2024, three months to 2024-05-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure4.0Income tax, Q1 FY2025, three months to 2024-08-31$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure(3.0)Income tax, Q2 FY2025, three months to 2024-11-30−$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(4.0)Income tax, Q3 FY2025, three months to 2025-02-28−$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure5.0Income tax, Q4 FY2025, three months to 2025-05-31$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure3.0Income tax, Q1 FY2026, three months to 2025-08-31$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure5.0Income tax, Q2 FY2026, three months to 2025-11-30$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure8.0Income tax, Q3 FY2026, three months to 2026-02-28$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure6.0Income tax, Q4 FY2026, three months to 2026-05-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure6.0Income tax, Q1 FY2027, three months to 2026-08-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Net income$k(1,507)Net income, Q2 FY2024, three months to 2023-11-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure(1,918)Net income, Q3 FY2024, three months to 2024-02-29−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure(1,421)Net income, Q4 FY2024, three months to 2024-05-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure(1,316)Net income, Q1 FY2025, three months to 2024-08-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(950)Net income, Q2 FY2025, three months to 2024-11-30−$950.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,163)Net income, Q3 FY2025, three months to 2025-02-28−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,544)Net income, Q4 FY2025, three months to 2025-05-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure2.0Net income, Q1 FY2026, three months to 2025-08-31$2.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure(1,320)Net income, Q2 FY2026, three months to 2025-11-30−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,312)Net income, Q3 FY2026, three months to 2026-02-28−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure(1,145)Net income, Q4 FY2026, three months to 2026-05-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure(1,232)Net income, Q1 FY2027, three months to 2026-08-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q2 FY2024, three months to 2023-11-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure(0.11)Diluted EPS, Q3 FY2024, three months to 2024-02-29−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figurenot reported(0.63)Diluted EPS, Q1 FY2025, three months to 2024-08-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure(0.06)Diluted EPS, Q2 FY2025, three months to 2024-11-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(0.48)Diluted EPS, Q3 FY2025, three months to 2025-02-28−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figurenot reported0.00Diluted EPS, Q1 FY2026, three months to 2025-08-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure(0.45)Diluted EPS, Q2 FY2026, three months to 2025-11-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(0.44)Diluted EPS, Q3 FY2026, three months to 2026-02-28−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figurenot reported(0.37)Diluted EPS, Q1 FY2027, three months to 2026-08-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q2 FY2024, three months to 2023-11-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure(0.11)Basic EPS, Q3 FY2024, three months to 2024-02-29−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figurenot reported(0.63)Basic EPS, Q1 FY2025, three months to 2024-08-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure(0.06)Basic EPS, Q2 FY2025, three months to 2024-11-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(0.48)Basic EPS, Q3 FY2025, three months to 2025-02-28−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figurenot reported0.00Basic EPS, Q1 FY2026, three months to 2025-08-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure(0.45)Basic EPS, Q2 FY2026, three months to 2025-11-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure(0.44)Basic EPS, Q3 FY2026, three months to 2026-02-28−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figurenot reported(0.37)Basic EPS, Q1 FY2027, three months to 2026-08-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure

Balance sheet

Cash and equivalents$2.7m, Q1 FY2027
Shareholders' equity$3.6m, Q1 FY2027
Biomerica Inc, balance sheet, quarterly
Line itemUnitQ3 FY20242024-02-29FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28period not labelled2025-05-13FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28FY20262026-05-26Q1 FY20272026-08-31
Cash and equivalents$m5.3Cash and equivalents, Q3 FY2024, at 2024-02-29$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure4.2Cash and equivalents, FY2024, at 2024-05-31$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-08-29, accession 0001641172-25-026041.Report this figure2.8Cash and equivalents, Q1 FY2025, at 2024-08-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure2.4Cash and equivalents, Q2 FY2025, at 2024-11-30$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure3.1Cash and equivalents, Q3 FY2025, at 2025-02-28$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure2.4Cash and equivalents, period not labelled, at 2025-05-13$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure2.4Cash and equivalents, FY2025, at 2025-05-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure3.1Cash and equivalents, Q1 FY2026, at 2025-08-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure2.5Cash and equivalents, Q2 FY2026, at 2025-11-30$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1.3Cash and equivalents, Q3 FY2026, at 2026-02-28$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure0.5Cash and equivalents, FY2026, at 2026-05-26$500.0k. XBRL concept us-gaap:Cash. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure2.7Cash and equivalents, Q1 FY2027, at 2026-08-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Current assets$m8.8Current assets, Q3 FY2024, at 2024-02-29$8.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure7.7Current assets, FY2024, at 2024-05-31$7.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-08-29, accession 0001641172-25-026041.Report this figure6.4Current assets, Q1 FY2025, at 2024-08-31$6.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure5.9Current assets, Q2 FY2025, at 2024-11-30$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure6.2Current assets, Q3 FY2025, at 2025-02-28$6.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure4.9Current assets, period not labelled, at 2025-05-13$4.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure4.9Current assets, FY2025, at 2025-05-31$4.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure5.9Current assets, Q1 FY2026, at 2025-08-31$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure5.2Current assets, Q2 FY2026, at 2025-11-30$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure4.1Current assets, Q3 FY2026, at 2026-02-28$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure4.0Current assets, FY2026, at 2026-05-31$4.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure5.4Current assets, Q1 FY2027, at 2026-08-31$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Total assets$m10.3Total assets, Q3 FY2024, at 2024-02-29$10.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure9.3Total assets, FY2024, at 2024-05-31$9.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-08-29, accession 0001641172-25-026041.Report this figure7.9Total assets, Q1 FY2025, at 2024-08-31$7.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure7.3Total assets, Q2 FY2025, at 2024-11-30$7.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure7.4Total assets, Q3 FY2025, at 2025-02-28$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure5.9Total assets, period not labelled, at 2025-05-13$5.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure5.9Total assets, FY2025, at 2025-05-31$5.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure6.9Total assets, Q1 FY2026, at 2025-08-31$6.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure6.0Total assets, Q2 FY2026, at 2025-11-30$6.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure4.9Total assets, Q3 FY2026, at 2026-02-28$4.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure6.8Total assets, FY2026, at 2026-05-31$6.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure8.1Total assets, Q1 FY2027, at 2026-08-31$8.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Current liabilities$m2.0Current liabilities, Q3 FY2024, at 2024-02-29$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure2.2Current liabilities, FY2024, at 2024-05-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-08-29, accession 0001641172-25-026041.Report this figure2.2Current liabilities, Q1 FY2025, at 2024-08-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure1.9Current liabilities, Q2 FY2025, at 2024-11-30$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure1.6Current liabilities, Q3 FY2025, at 2025-02-28$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure1.7Current liabilities, period not labelled, at 2025-05-13$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure1.7Current liabilities, FY2025, at 2025-05-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure1.7Current liabilities, Q1 FY2026, at 2025-08-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure1.6Current liabilities, Q2 FY2026, at 2025-11-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1.6Current liabilities, Q3 FY2026, at 2026-02-28$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure2.5Current liabilities, FY2026, at 2026-05-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure2.8Current liabilities, Q1 FY2027, at 2026-08-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Total liabilities$m2.5Total liabilities, Q3 FY2024, at 2024-02-29$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure2.7Total liabilities, FY2024, at 2024-05-31$2.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-08-29, accession 0001641172-25-026041.Report this figure2.5Total liabilities, Q1 FY2025, at 2024-08-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure2.2Total liabilities, Q2 FY2025, at 2024-11-30$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure1.8Total liabilities, Q3 FY2025, at 2025-02-28$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure1.8Total liabilities, period not labelled, at 2025-05-13$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure1.8Total liabilities, FY2025, at 2025-05-31$1.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure1.7Total liabilities, Q1 FY2026, at 2025-08-31$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure1.6Total liabilities, Q2 FY2026, at 2025-11-30$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure1.6Total liabilities, Q3 FY2026, at 2026-02-28$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure4.1Total liabilities, FY2026, at 2026-05-31$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure4.4Total liabilities, Q1 FY2027, at 2026-08-31$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Shareholders' equity$m7.8Shareholders' equity, Q3 FY2024, at 2024-02-29$7.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure6.6Shareholders' equity, FY2024, at 2024-05-31$6.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-31, accession 0001493152-26-040851.Report this figure5.3Shareholders' equity, Q1 FY2025, at 2024-08-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure5.1Shareholders' equity, Q2 FY2025, at 2024-11-30$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure5.5Shareholders' equity, Q3 FY2025, at 2025-02-28$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure4.1Shareholders' equity, period not labelled, at 2025-05-13$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure4.1Shareholders' equity, FY2025, at 2025-05-31$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure5.2Shareholders' equity, Q1 FY2026, at 2025-08-31$5.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure4.4Shareholders' equity, Q2 FY2026, at 2025-11-30$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure3.3Shareholders' equity, Q3 FY2026, at 2026-02-28$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure2.6Shareholders' equity, FY2026, at 2026-05-31$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure3.6Shareholders' equity, Q1 FY2027, at 2026-08-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure

Cash flow

Operating cash flow−$802.0k, Q1 FY2027
Capital expenditure$24.0k, Q4 FY2024
Biomerica Inc, cash flow, quarterly
Line itemUnitQ2 FY20242023-11-30Q3 FY20242024-02-29Q4 FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q4 FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q4 FY20262026-05-31Q1 FY20272026-08-31
Operating cash flow$k(842)Operating cash flow, Q2 FY2024, three months to 2023-11-30−$842.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-01-14, accession 0001493152-25-002209. Derived: 6-month figure less the 3-month figure.Report this figure(1,801)Operating cash flow, Q3 FY2024, three months to 2024-02-29−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-14, accession 0001641172-25-004571. Derived: 9-month figure less the 6-month figure.Report this figure(1,044)Operating cash flow, Q4 FY2024, three months to 2024-05-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figure(1,344)Operating cash flow, Q1 FY2025, three months to 2024-08-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure(791)Operating cash flow, Q2 FY2025, three months to 2024-11-30−$791.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-14, accession 0001493152-26-002286. Derived: 6-month figure less the 3-month figure.Report this figure(1,045)Operating cash flow, Q3 FY2025, three months to 2025-02-28−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-13, accession 0001493152-26-016388. Derived: 9-month figure less the 6-month figure.Report this figure(662)Operating cash flow, Q4 FY2025, three months to 2025-05-31−$662.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure(268)Operating cash flow, Q1 FY2026, three months to 2025-08-31−$268.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure(991)Operating cash flow, Q2 FY2026, three months to 2025-11-30−$991.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-14, accession 0001493152-26-002286. Derived: 6-month figure less the 3-month figure.Report this figure(1,250)Operating cash flow, Q3 FY2026, three months to 2026-02-28−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-13, accession 0001493152-26-016388. Derived: 9-month figure less the 6-month figure.Report this figure(912)Operating cash flow, Q4 FY2026, three months to 2026-05-31−$912.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-31, accession 0001493152-26-040851. Derived: 12-month figure less the 9-month figure.Report this figure(802)Operating cash flow, Q1 FY2027, three months to 2026-08-31−$802.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure
Capital expenditure$k6.0Capital expenditure, Q2 FY2024, three months to 2023-11-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-01-14, accession 0001493152-25-002209. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-02-29$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-14, accession 0001641172-25-004571. Derived: 9-month figure less the 6-month figure.Report this figure24.0Capital expenditure, Q4 FY2024, three months to 2024-05-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-08-29, accession 0001641172-25-026041. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)3.30m, Q1 FY2027
Biomerica Inc, shares, quarterly
Line itemUnitQ2 FY20232022-11-30Q3 FY20232023-02-28Q1 FY20242023-08-31Q2 FY20242023-11-30Q3 FY20242024-02-29Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q1 FY20272026-08-31
Diluted shares (weighted)m shares13.5Diluted shares (weighted), Q2 FY2023, three months to 2022-11-3013,455,166 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-01-16, accession 0001493152-24-002331.Report this figure13.5Diluted shares (weighted), Q3 FY2023, three months to 2023-02-2813,481,490 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-12, accession 0001493152-24-014474.Report this figure16.8Diluted shares (weighted), Q1 FY2024, three months to 2023-08-3116,821,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-15, accession 0001493152-24-041156.Report this figure16.8Diluted shares (weighted), Q2 FY2024, three months to 2023-11-3016,821,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-01-14, accession 0001493152-25-002209.Report this figure16.8Diluted shares (weighted), Q3 FY2024, three months to 2024-02-2916,821,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-14, accession 0001641172-25-004571.Report this figure2.1Diluted shares (weighted), Q1 FY2025, three months to 2024-08-312,103,154 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-14, accession 0001493152-25-018043.Report this figure2.1Diluted shares (weighted), Q2 FY2025, three months to 2024-11-302,140,179 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure2.4Diluted shares (weighted), Q3 FY2025, three months to 2025-02-282,398,285 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure2.6Diluted shares (weighted), Q1 FY2026, three months to 2025-08-312,638,699 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure2.9Diluted shares (weighted), Q2 FY2026, three months to 2025-11-302,908,164 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-01-14, accession 0001493152-26-002286.Report this figure3.0Diluted shares (weighted), Q3 FY2026, three months to 2026-02-283,010,308 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-13, accession 0001493152-26-016388.Report this figure3.3Diluted shares (weighted), Q1 FY2027, three months to 2026-08-313,295,939 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure

Shares outstanding: 4.60mShares outstanding, period not labelled, at 2026-10-154,598,968 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-15, accession 0001493152-26-047271.Report this figure at Oct 15, 2026, from the cover of the 10-Q filed Oct 15, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. Listed shows no prices and gives no investment advice.